Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1,4-Dichloro-2-butene, (2E)- → trans-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-enyloxy}-2-methyl-benzothiazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1,4-Dichloro-2-butene, (2E)- | HCID 642197 | — |
| 반응물 | 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazine | HCID 2735936 | — |
| 반응물 | trans-7-(3-Chloroallyloxy)-2-methyl-benzothiazole | HCID 23289321 | — |
| 생성물 | trans-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-enyloxy}-2-methyl-benzothiazole | HCID 23289240 | — |
| 생성물 | trans-7-(3-Chloroallyloxy)-2-methyl-benzothiazole | HCID 23289321 | — |
반응 단계
The title compound was prepared according to Method GA from trans-7-(3-chloro-allyloxy)-2-methyl-benzothiazole and 1-(10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-yl)piperazine. mp 151-152° C.; LSIMS m/z 496. The trans-7-(3-chloroallyloxy)-2-methyl-benzothiazole was prepared by Method IV with trans-1,4-dichloro-2-butene as the alkylating agent.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06130217 |
| 출처 데이터셋 | uspto-grants-2000_10 |
| ORD ID | ord-0ee17759ccbc4c78b10e19e429ca0ccc |
| 출처 메모 | uspto-grants-2000_10 |